Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05,…
Pharmaceuticals, Biotechnology and Life Sciences
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05,…
— OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in…
Strengthens balance sheet with non-dilutive capital to enable further pipeline development and related strategic prioritiesCAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE…
CINCINATTI, OH., Oct. 03, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Onconetix,…
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and…
IRVINE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in…
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct.…
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in…
Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad LaboratoriesIRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) —…
TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a…